Sun Pharma beats estimates; Q1 profit up by 31% to ₹1387 crore

Must Read

Howdy, Modi! : World media reactions on Modi-Trump’ grand Houston Event address

New Delhi, Sep 23: United States President Donald Trump and Indian Prime Minister Narendra Modi on late Sunday shared...

Howdy Modi : Modi-Trump mark history in US-India relationship with great show at Houston

Houston, Sep 22:  Modi, delivering his speech at the historic event, talks about the development underwent over five years...

ECI announces dates of Maharashtra & Haryana elections; Single Phase Election on October 21; Result on 24th

Election Commission of India has announced the dates of much-awaited state elections. According to the Chief Election Commissioner, Sunil...

Sun Pharmaceuticals has said on tuesday that its Q1 net profit rose to 31.2 per cent year-on-year to ₹1387 crore in the June quarter from ₹1057 crore in the corresponding quarter last year.

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients primarily in India and the United States.

It has said on tuesday that its Q1 net profit rose to 31.2 per cent year-on-year to ₹1387 crore in the June quarter from ₹1057 crore in the corresponding quarter last year.

The experts of an ET NOW poll survey had expected ₹994 crore profit for the quarter.

Higher profit came on the back of a forex gain of Rs 67 crore compared to a loss a year ago. Restructuring of domestic business had hurt the company’s bottom line in the quarter ended March.

Sun Pharma’s revenue increased 15.9 percent over the last year to Rs 8,374 crore in the April-June period—in line with the Rs 8,120-crore estimate.

Sun Pharma’s earnings before interest, tax, depreciation and amortisation rose 13.7 percent to Rs 1,696 crore. Its operating margin narrowed 50 basis points to 23 percent.

Shares of the drugmaker rose as much as 5.3 per cent to ₹444.5.The stock has risen 0.5 percent so far this year compared with a more than 10 percent fall in the benchmark NSE Nifty Pharma Index. Besides Divi’s Laboratories Ltd., Sun Pharma is the only stock that has gained in the index.This is even when the BSE sensex was down 600 points.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

Army kills 35 Jaish, Hizb militants across LoC

Srinagar, Oct 20 (IANS) At least 35 Jaish-e-Mohammed and Hizbul Mujahideen militants were killed in retaliatory firing and shelling...

Steven Spielberg: I was ashamed of lots of things

Los Angeles, Oct 20 (IANS) Filmmaker Steven Spielberg was ashamed of a lot of things while growing up, and says he was bullied for...

Why has Elon Musk suddenly gone offline?

San Francisco, Oct 20 (IANS) It has been a couple of days since SpaceX CEO Elon Musk, who has courted several controversies with his...

Smartphone can help patients take pills on time

Buenos Aires, Oct 20 (IANS) The smartphone is now frequently blamed for a lot of health problems, but it appears that the device may...

AI, digital marketing key skills to boost growth

New Delhi, Oct 20 (IANS) Artificial Intelligence (AI) and Machine Learning (ML), digital marketing and design thinking are the top skills that organisations will...
- Advertisement -

More Articles Like This